Evotec: How Low A Company May Go While Still Being Attractive
Source: SeekingAlpha
2025-12-08 04:10:22 ET
There comes a time in an investment where you need to ask yourself whether you are looking at a potential capital loss. For Evotec ( EVO ), I believe that possibility is at least worth asking at this point. Because the company is speculative, I don't hold a big position in it. My stake is very small, below 0.1% - but any money or capital is still capital, and the fact that my investment isn't big is not an excuse to neglect coverage or, if that is required, own up to mistakes and learning experiences....
Read the full article on Seeking Alpha
For further details see:
Evotec: How Low A Company May Go While Still Being Attractive
Evotec SE
NASDAQ: EVOTF
EVOTF Trading
177900.0% G/L:
$8.01 Last:
2,814 Volume:
$8.01 Open:
EVOTF Latest News
January 08, 2026 01:50:00 am
Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
January 02, 2026 12:30:00 am
Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations
December 08, 2025 01:20:00 am
Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz
December 04, 2025 02:50:00 am
Evotec-Partner Bayer Starts Phase 2 Study for Treatment of Patients with Alport Syndrome
EVOTF Stock Data
$326,390,317
157,381,715
N/A
374
N/A
Biotechnology & Life Sciences
Healthcare
DE
Hamburg
